Bristol/Sanofi To Seek Plavix Indication For Subset Of Heart Attack Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
The companies plan to file a clopidogrel supplemental NDA for prevention of clinical events in patients with a history of acute ST-segment elevation myocardial infarction. The filing is planned by year-end, based on results of the COMMIT and CLARITY studies, Bristol says.